Introduction
Non-invasive Prenatal Testing Version 2.0 (NIPT v2.0) is a newly ungraded product of NIPT v1.0, which can test 132 chromosomal diseases with clinical significance.
Applicable
- NIPT v2.0 is appropriate for pregnant women with fully informed the technical characteristics of prenatal screening and diagnostic methods, and voluntarily choose NIPT v2.0, particularly those with a singleton or twin pregnancy over 12+0 weeks of gestation;
- Pregnant women who are at moderate risk of common chromosome aneuploidy through Down's serological screening and ultrasonic imaging examination;
- Pregnant women with contraindications to invasive prenatal diagnosis (such as threatened abortion, fever, bleeding tendency, and unhealed infection, etc.);
- Pregnant women who missed the optimal time for serological screening or prenatal diagnosis.